文献速递生殖医学

卵巢组织冻存的临床困境

Clinical dilemmas in ovarian tissue cryopreservation.
PubMed 文献 · Fertil Steril · 2024-05-31

卵巢组织冻存(OTC)作为生育力保存策略在全球日益增多,冻存组织再植入后活产数快速增长。但青春期前冻存组织及累及卵巢疾病(如特纳综合征)的疗效证据仍非常有限。本文综述了患者选择、预后差患者应用、恶性细胞污染组织再植入风险及卵巢内在疾病中OTC作用等临床与伦理困境。

要点

  • OTC在全球作为青春期后女性及青春期前女孩的生育力保存策略日益增多。
  • 青春期前冻存组织及累及卵巢疾病(如特纳综合征)的疗效证据仍非常有限。
  • 综述讨论患者选择、预后差患者应用、恶性细胞污染再植入风险及卵巢内在疾病中OTC作用等困境。

核心结论

  • OTC虽日益成为更成熟的实践,但从实践和伦理角度仍存在若干临床困境。

研究设计与样本

  • 综述,讨论卵巢组织冻存的临床困境。

主要发现

  • 冻存卵巢皮质再植入后活产数快速增长。
  • 青春期前冻存组织或累及卵巢疾病(如特纳综合征)的疗效证据仍非常有限。

局限性

  • 青春期前冻存组织或累及卵巢疾病(如特纳综合征)的疗效证据仍非常有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ovarian tissue cryopreservation (OTC) is increasingly offered globally as a fertility preservation strategy for both postpubertal women and prepubertal girls, with subsequent reimplantation of cryopreserved ovarian cortex resulting in a rapidly growing number of live births. There remains very limited evidence of efficacy from tissue stored when the patient was prepubertal or from conditions affecting the ovary directly, e.g., Turner syndrome. Although OTC is becoming a more established practice, several clinical dilemmas remain from a practical and ethical standpoint. This review discusses the challenges regarding optimal patient selection for the procedure, the use of OTC in patients with a poor prognosis, the potential of reimplantation of tissue contaminated with malignant cells, and the role of OTC in those with an intrinsic ovarian disorder.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Dunlop CE, Anderson RA. Clinical dilemmas in ovarian tissue cryopreservation. Fertil Steril. 2024. PMID: 38825305. doi:10.1016/j.fertnstert.2024.05.167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。